Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
In the latest session, Spero Therapeutics Inc (NASDAQ: SPRO) closed at $2.2 down -4.35% from its previous closing price of $2.3. In other words, the price has decreased by -$4.35 from its previous closing price. On the day, 0.88 million shares were traded. SPRO stock price reached its highest trading level at $2.31 during the session, while it also had its lowest trading level at $2.1749.
Ratios:
For a deeper understanding of Spero Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.56 and its Current Ratio is at 2.56. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.06.
On September 23, 2022, Evercore ISI Upgraded its rating to Outperform which previously was In-line and also upped its target price recommendation from $2 to $8.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 05 ’25 when Keutzer Timothy sold 56,537 shares for $0.78 per share. The transaction valued at 44,099 led to the insider holds 741,439 shares of the business.
Rajavelu Esther sold 20,689 shares of SPRO for $16,137 on Feb 05 ’25. The CFO & CBO now owns 724,720 shares after completing the transaction at $0.78 per share. On Feb 05 ’25, another insider, Shukla Sath, who serves as the CEO & President of the company, sold 155,333 shares for $0.78 each. As a result, the insider received 121,160 and left with 1,736,883 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRO now has a Market Capitalization of 123003320 and an Enterprise Value of 78076408. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.35 while its Price-to-Book (P/B) ratio in mrq is 3.64. Its current Enterprise Value per Revenue stands at 1.751 whereas that against EBITDA is -1.067.
Stock Price History:
The Beta on a monthly basis for SPRO is 1.37, which has changed by 0.56028366 over the last 52 weeks, in comparison to a change of 0.15366066 over the same period for the S&P500. Over the past 52 weeks, SPRO has reached a high of $3.22, while it has fallen to a 52-week low of $0.51. The 50-Day Moving Average of the stock is -8.43%, while the 200-Day Moving Average is calculated to be 69.13%.
Shares Statistics:
For the past three months, SPRO has traded an average of 4.43M shares per day and 601240 over the past ten days. A total of 55.90M shares are outstanding, with a floating share count of 37.21M. Insiders hold about 33.45% of the company’s shares, while institutions hold 20.73% stake in the company. Shares short for SPRO as of 1752537600 were 1217101 with a Short Ratio of 0.28, compared to 1749772800 on 1612678. Therefore, it implies a Short% of Shares Outstanding of 1217101 and a Short% of Float of 2.6600001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
